New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?
What rheumatologists should know about complying with the PPSA when it goes into effect on August 1
How Rheumatologists Can Connect with Congress during August Recess
Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices
Rheumatology Drug Research Should Focus on Particular Groups of Patients
An analysis of risks and benefits of drugs in specific types of patients will help rheumatologists provide better treatment
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
What Rheumatologists Need to Know About the Physician Payment Sunshine Act
The federal act mandates transparency within physician–industry relationship
Researchers Explore HLA-B27’s Role in the Development of Spondylitis
New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)
Can Lubricating Joints Prevent Osteoarthritis?
Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)
Small Fiber Function May Be Linked to Fibromyalgia
Researchers show, for the first time, that small fiber function and morphology is impaired in patients with fibromyalgia. (posted June 18, 2013)
Th17 May Contribute to Bone Destruction by Modifying Osteoclasts
New research describes the role of RANKL-expressing Th17 cells in inflammatory bone destruction. (posted June 3, 2013)
- « Previous Page
- 1
- …
- 189
- 190
- 191
- 192
- 193
- …
- 248
- Next Page »